Journal
AMERICAN JOURNAL OF HUMAN GENETICS
Volume 103, Issue 3, Pages 377-388Publisher
CELL PRESS
DOI: 10.1016/j.ajhg.2018.08.001
Keywords
-
Categories
Funding
- Stanford Center for Computational, Evolutionary and Human Genomics Fellowship
- NIH [R01HL109512, R01HL134817, R33HL120757, R01DK107437, R01HL139478, R00HL125912]
- NHLBI [R33HL120757]
- NHGRI
- ENCODE4 [U01HG009431]
- NIH Common Fund
- GTEx Program [R01MH101814]
- NHGRI
- Non-Coding Variants Program [R01HG008150]
- Edward Mallinckrodt, Jr. Foundation
Ask authors/readers for more resources
Coronary artery disease (CAD) is the leading cause of death globally. Genome-wide association studies (GWASs) have identified more than 95 independent loci that influence CAD risk, most of which reside in non-coding regions of the genome. To interpret these loci, we generated transcriptome and whole-genome datasets using human coronary artery smooth muscle cells (HCASMCs) from 52 unrelated donors, as well as epigenomic datasets using ATAC-seq on a subset of 8 donors. Through systematic comparison with publicly available datasets from GTEx and ENCODE projects, we identified transcriptomic, epigenetic, and genetic regulatory mechanisms specific to HCASMCs. We assessed the relevance of HCASMCs to CAD risk using transcriptomic and epigenomic level analyses. By jointly modeling eQTL and GWAS datasets, we identified five genes (SIPA1, TCF21, SMAD3, FES, and PDGFRA) that may modulate CAD risk through HCASMCs, all of which have relevant functional roles in vascular remodeling. Comparison with GTEx data suggests that SIPA1 and PDGFRA influence CAD risk predominantly through HCASMCs, while other annotated genes may have multiple cell and tissue targets. Together, these results provide tissue-specific and mechanistic insights into the regulation of a critical vascular cell type associated with CAD in human populations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available